The company and all members of the board of directors guarantee that the information disclosed is true, accurate, and complete, without any false records, misleading statements, or significant omissions.
Special Reminder:
- The shares being released from restrictions are part of the shares issued prior to the initial public offering of Jiangsu Dongxing Smart Medical Technology Co., Ltd. (hereinafter referred to as "the Company").
- The number of shareholders involved in this release is 4, with a total of 31,442,934 shares being released, accounting for 31.3885% of the Company's total share capital. The lock-up period is 36 months from the date of the Company's initial public offering and listing, and due to the closing price being below the issue price of 44.09 yuan/share for 20 consecutive trading days within 6 months after the listing, the lock-up period for the 4 shareholders applying for the release is extended to 42 months from the listing date. After the release, the actual number of shares available for circulation is 11,415,134 shares, accounting for 11.3954% of the total share capital.
- The listing and circulation date for the released shares is June 1, 2026 (Monday).
I. Company Stock Issuance and Capital Situation
According to the China Securities Regulatory Commission's approval (Zheng Jian Xu Ke [2022] No. 1922) for Jiangsu Dongxing Smart Medical Technology Co., Ltd.'s initial public offering, the Company issued 25,043,334 ordinary shares (A shares) and was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on November 30, 2022. After the initial public offering, the total share capital of the Company is 100,173,334 shares, of which 77,541,798 shares are subject to trading restrictions, accounting for 77.4076% of the total share capital after issuance; 22,631,536 shares are unrestricted, accounting for 22.5924%.
On June 15, 2023, the number of shareholders releasing shares from the offline allocation was 5,594, with a total of 1,277,754 shares released. For details, please refer to the announcement disclosed by the Company on June 12, 2023, on the Giant Tide Information Network (www.cninfo.com.cn) (Announcement No.: 2023-043).
On December 1, 2023, the number of shareholders releasing shares prior to the initial public offering and strategic placement was 107, with a total of 44,096,110 shares released. For details, please refer to the announcement disclosed by the Company on November 29, 2023, on the Giant Tide Information Network (Announcement No.: 2023-070).
On May 31, 2024, the number of shareholders releasing shares prior to the initial public offering was 2, with a total of 725,000 shares released. For details, please refer to the announcement disclosed by the Company on May 28, 2024, on the Giant Tide Information Network (Announcement No.: 2024-037).
Since the Company's initial public offering and listing, there have been no changes in the number of shares due to issuance, repurchase, cancellation, or distribution of stock dividends or capital reserve transfers. As of the date of this announcement, the total share capital of the Company is 100,173,334 shares, of which 68,163,400 shares are unrestricted, accounting for 68.05%; 32,009,934 shares are restricted, accounting for 31.95%. The shares being released from restrictions are part of the shares issued prior to the initial public offering, with a lock-up period of 36 months from the date of the Company's initial public offering and listing, and due to the stock price falling below the issue price of 44.09 yuan/share for 20 consecutive trading days within 6 months after the listing, the lock-up period for the 4 shareholders applying for the release is extended to 42 months. The number of shares being released is 31,442,934 shares, accounting for 31.3885% of the total share capital, with 11,415,134 shares available for circulation, accounting for 11.3954% of the total share capital. The lock-up period for these restricted shares is about to expire and will be listed for circulation starting June 1, 2026.